As of 2026-07-04, the Intrinsic Value of Solid Biosciences Inc (SLDB) is -9.74 USD. This SLDB valuation is based on the model Peter Lynch Fair Value. With the current market price of 10.84 USD, the upside of Solid Biosciences Inc is -189.85%.
Based on its market price of 10.84 USD and our intrinsic valuation, Solid Biosciences Inc (SLDB) is overvalued by 189.85%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -9.74 - -9.74 | -9.74 | -189.85% |
| P/E | (30.19) - (34.48) | (32.29) | -397.9% |
| DDM - Stable | (10.72) - (29.57) | (20.14) | -285.8% |
| DDM - Multi | (0.31) - (0.68) | (0.43) | -104.0% |
| Market Cap (mil) | 1,067.20 |
| Beta | 0.65 |
| Outstanding shares (mil) | 98.45 |
| Enterprise Value (mil) | 770.10 |
| Market risk premium | 4.60% |
| Cost of Equity | 13.33% |
| Cost of Debt | 5.00% |
| WACC | 8.50% |